NNC0480-0389
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NNC0480-0389, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes [Phase 2]